Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Intensive Care Medicine

• Publication date

  2005-09-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00134-005-2697-yPMID 16151723
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines

  2003cited by this paper
• International Conference for the Development of Consensus on the Diagnosis and Treatment of Ventilator-associated Pneumonia.

  2001influential reference
• A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting.

  2000cited by this paper
• Invasive and Noninvasive Strategies for Management of Suspected Ventilator-Associated Pneumonia

  2000cited by this paper
• Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices.

  1999cited by this paper
• Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

  1999cited by this paper
• The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group.

  1999cited by this paper
• Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

  1998cited by this paper
• Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study.

  1998cited by this paper
• Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

  1998cited by this paper
• The value of routine microbial investigation in ventilator-associated pneumonia.

  1997cited by this paper
• Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia.

  1997cited by this paper
• Therapy for nosocomial pneumonia

  1997cited by this paper
• Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995.

  1996cited by this paper
• Pneumonia in intubated trauma patients. Microbiology and outcomes.

  1996cited by this paper
• Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies: A consensus statement

  1996cited by this paper
• Validation of different techniques for the diagnosis of ventilator-associated pneumonia. Comparison with immediate postmortem pulmonary biopsy.

  1994cited by this paper
• Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes.

  1994cited by this paper
• Invasive diagnostic testing should be routinely used to manage ventilated patients with suspected pneumonia.

  1994cited by this paper
• Specificity of endotracheal aspiration, protected specimen brush, and bronchoalveolar lavage in mechanically ventilated patients.

  1993cited by this paper
• The effect of antibiotic therapy on recovery of intracellular bacteria from bronchoalveolar lavage in suspected ventilator-associated nosocomial pneumonia.

  1993cited by this paper
• Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia.

  1993influential reference
• Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

  1993cited by this paper
• Pneumonia due to Haemophilus influenzae among mechanically ventilated patients. Incidence, outcome, and risk factors.

  1992cited by this paper
• The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults.

  1991cited by this paper
• Epidemiology and risk factors of pneumonia in critically ill patients. Intensive Care Unit Group for Infection Control.

  1991cited by this paper
• Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients.

  1991cited by this paper
• Protected bronchoalveolar lavage. A new bronchoscopic technique to retrieve uncontaminated distal airway secretions.

  1991cited by this paper
• Epidemiology and risk factors of pneumonia in critically ill patients

  1991cited by this paper
• Pneumonia in the Critically III Hospitalized Patient

  1990cited by this paper
• Pneumonia in the critically ill hospitalized patient.

  1990cited by this paper
• Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques.

  1989cited by this paper
• Cefoperazone versus combination antibiotic therapy of hospital-acquired pneumonia.

  1988cited by this paper
• Detection of nosocomial lung infection in ventilated patients. Use of a protected specimen brush and quantitative culture techniques in 147 patients.

  1988cited by this paper
• Treatment with aztreonam or tobramycin in critical care patients with nosocomial gram-negative pneumonia.

  1985cited by this paper
• Ceftazidime versus Tobramycin/Ticarcillin in Treating Hospital Acquired Pneumonia and Bacteremia

  1984cited by this paper

• Nosocomial and Ventilator-associated Pneumonia

  2025cites this paper
• Microbiological Etiology and Detection of Drug-Resistant Bacteria in Pneumonia in Patients with Organophosphate Poisoning in the Intensive Care Unit

  2025cites this paper
• Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter (ESKAPE) Pathogens and Colistin Resistance in Ventilator-Associated Pneumonia: A Prospective Cross-Sectional Study

  2025cites this paper
• High Mortality and Pathogen Burden of Ventilator-Associated Pneumonia in Al Jouf, Saudi Arabia: A Retrospective ICU Study

  2025cites this paper
• Baseline Characteristics of Bronchial Secretions and Bronchoalveolar Lavage Fluid in Patients with Ventilator-Associated Pneumonia

  2025cites this paper
• Update der S3-Leitlinie: Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie

  2025cites this paper
• Microbial profile and antimicrobial resistance patterns in ventilator-associated pneumonia (VAP): A cross-sectional study from Syria

  2025cites this paper
• Ventilator-associated pneumonia: pathobiological heterogeneity and diagnostic challenges

  2024cites this paper
• Key summary of German national guideline for adult patients with nosocomial pneumonia- Update 2024 Funding number at the Federal Joint Committee (G-BA): 01VSF22007

  2024cites this paper
• Guidelines for Antibiotics Prescription in Critically Ill Patients

  2024cites this paper
• A Comparison of Different Strategies for Optimizing the Selection of Empiric Antibiotic Therapy for Pneumonia Caused by Gram-Negative Bacteria in Intensive Care Units: Unit-Specific Combination Antibiograms Versus Patient-Specific Risk Factors

  2024cites this paper
• WNT9A Affects Late-Onset ARDS and 28-Day Survival: Evidence from a Three-Step Multi-Omics Study.

  2023cites this paper
• Using Methicillin-Resistant Staphylococcus aureus Nasal Screens to Rule Out Methicillin-Resistant S aureus Pneumonia in Surgical Intensive Care Units.

  2023cites this paper
• Early-Onset Ventilator-Associated Pneumonia in Pediatric Severe Traumatic Brain Injury

  2023cites this paper
• Risk Factors and Algorithms for the Empirical Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia.

  2022cites this paper
• Some concerns about the systematic review of diagnostic and prognostic prediction models in ventilator-associated pneumonia.

  2022cites this paper
• A Narrative Review on the Approach to Antimicrobial Use in Ventilated Patients with Multidrug Resistant Organisms in Respiratory Samples—To Treat or Not to Treat? That Is the Question

  2022cites this paper
• Rate of Multidrug-resistance to Antimicrobial Drugs in Patients in Pediatric Neurointensive Care

  2022cites this paper
• Factors Affecting Incidence of Ventilator-Associated Pneumonia With Multidrug-Resistant Microbes in Intensive Care Unit

  2022cites this paper
• Bacteriological profile and antimicrobial susceptibility pattern of endotracheal tube secretion of patients in ICUs of a tertiary care hospital in Punjab

  2021cites this paper
• Effects of CNS Injury-Induced Immunosuppression on Pulmonary Immunity

  2021cites this paper
• Antimicrobial Susceptibility among Pathogens Isolated in Early- versus Late-Onset Ventilator-Associated Pneumonia

  2021cites this paper
• The utility of a modified technique for lower respiratory tract sampling in COVID-19 ICU and review of diagnostic approaches in suspected ventilator associated pneumonia

  2021cites this paper
• Microorganisms and clinical outcomes of early- and late-onset ventilator-associated pneumonia at Srinagarind Hospital, a tertiary center in Northeastern Thailand

  2020cites this paper
• A comparison of diagnostic algorithms and clinical parameters to diagnose ventilator-associated pneumonia: a prospective observational study

  2020cites this paper
• Microorganisms and clinical outcomes of early- and late-onset ventilator-associated pneumonia at Srinagarind Hospital, a tertiary center in Northeastern Thailand

  2020cites this paper
• COMMUNITY-ACQUIRED PNEUMONIA IN THE INTENSIVE CARE UNIT What are the Common Organisms Causing Community-Acquired Pneumonia in Intensive Care Unit Worldwide and India ?

  2019cites this paper
• Ventilator-Associated Pneumonia

  2019cites this paper
• Potential Impact of HAP Guidelines on Empiric Antibiotics: An Evaluation of 113 VA Medical Centers.

  2019cites this paper
• Ventilator-Associated Pneumonia in Neurosurgical Patients: A Tertiary Care Center Study

  2019cites this paper
• Guidelines for Antibiotic Prescription in Intensive Care Unit

  2019cites this paper
• Potential Impact of Hospital-acquired Pneumonia Guidelines on Empiric Antibiotics An Evaluation of 113 Veterans Affairs Medical Centers

  2019cites this paper
• Nozokomiální pneumonie

  2018cites this paper
• Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie – Update 2017

  2018cites this paper
• Significant Publications on Infectious Diseases Pharmacotherapy in 2016

  2018cites this paper
• The Current Epidemiological Landscape of Ventilator-associated Pneumonia in the Intensive Care Unit: A Multicenter Prospective Observational Study in China.

  2018cites this paper
• Ventilator-Associated Pneumonia and its Treatment in Adults

  2018cites this paper
• Early-Onset Ventilator-Associated Pneumonia in Patients with Severe Traumatic Brain Injury: Incidence, Risk Factors, and Consequences in Cerebral Oxygenation and Outcome

  2017cites this paper
• 【特集】「成人肺炎診療ガイドライン2017」を読み解く 人工呼吸器関連肺炎（VAP）

  2017cites this paper
• Respective impact of implementation of prevention strategies, colonization with multiresistant bacteria and antimicrobial use on the risk of early- and late-onset VAP: An analysis of the OUTCOMEREA network

  2017cites this paper
• Management of mechanical ventilation in patients with hospital-acquired pneumonia: A retrospective, observational study.

  2017cites this paper
• Emerging Trends of Nosocomial Pneumonia in Intensive Care Unit of a Tertiary Care Public Teaching Hospital in Western India

  2017cites this paper
• Controversies and advances in the management of ventilator associated pneumonia

  2017cites this paper
• Empirical treatment of adults with hospital-acquired pneumonia: lights and shadows of the 2016 Clinical Practice ATS/IDSA Guidelines.

  2017cites this paper
• Original Article Infection Route Analysis of Ventilator Associated Pneumonia

  2017cites this paper
• An Investigation into the Pattern of Antibiotic Resistance of Bacteria Causing Ventilator – Associated Pneumonia in ICU

  2017cites this paper
• Assessment of surgical risk factors in the development of ventilator-associated pneumonia in neurosurgical intensive care unit patients: Alarming observations

  2017cites this paper
• Management of Adults with Hospital-acquired and Ventilator-associated Pneumonia.

  2016cites this paper
• Microbial Etiology of Pneumonia: Epidemiology, Diagnosis and Resistance Patterns

  2016cites this paper
• Estudo prospectivo comparativo de métodos diagnósticos etiológicos da pneumonia associada à ventilação mecânica

  2016cites this paper
• Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.

  2016cites this paper
• 34 – Ventilator-Associated Pneumonia

  2016cites this paper
• The impact of onset time on the isolated pathogens and outcomes in ventilator associated pneumonia.

  2016cites this paper
• Case fatality rate related to nosocomial and ventilator-associated pneumonia in an ICU: a single-centre retrospective cohort study

  2016cites this paper
• The incidence of nosocomial infections in patients with isolated severe traumatic brain injury

  2015cites this paper
• Early-onset pneumonia after out-of-hospital cardiac arrest.

  2015cites this paper
• Risk factors for ventilator-associated pneumonia in patients with severe traumatic brain injury in a Serbian trauma centre.

  2015cites this paper
• Empirical antibiotic therapy for pneumonia in intensive care units: a multicentre, retrospective analysis of potentially pathogenic microorganisms identified by endotracheal aspirates cultures

  2015cites this paper
• Resistance patterns and outcomes in intensive care unit (ICU)-acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms.

  2015cites this paper
• Risks for multidrug-resistant pathogens in the ICU

  2014cites this paper
• Ventilator-associated pneumonia in a tertiary care intensive care unit: Analysis of incidence, risk factors and mortality

  2014influential citation
• How to treat VAP due to MDR pathogens in ICU patients

  2014cites this paper
• Ventilator-associated pneumonia: present understanding and ongoing debates

  2014cites this paper
• Epidemiology and outcomes of ventilator-associated pneumonia in northern Brazil: an analytical descriptive prospective cohort study

  2013cites this paper
• Prospective Multicenter Study of Pathogen Distributions in Early-Onset and Late-Onset Hospital-Acquired Pneumonia in China

  2013cites this paper
• Emergence of methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of late-onset nosocomial pneumonia in intensive care patients in the USA.

  2013cites this paper
• Short- vs long-duration antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis.

  2013cites this paper
• Impact of guidelines for stratification of community acquired and hospital pneumonia severity and treatment

  2012cites this paper
• Infection Route Analysis of Ventilator Associated Pneumonia

  2012cites this paper
• Ventilatör Ilişkili Pnömoni ile Gastroözofageal Reflü ve Trakeabronşial Aspirasyon Arasındaki Ilişki

  2012cites this paper
• Association between systemic corticosteroids and outcomes of intensive care unit–acquired pneumonia*

  2012cites this paper
• Early-Onset Ventilator-Associated Pneumonia in Adults Randomized Clinical Trial: Comparison of 8 versus 15 Days of Antibiotic Treatment

  2012cites this paper
• Should the ATS/IDSA Guidelines for Hospital-acquired and Ventilator-associated Pneumonia be Reevaluated?

  2011cites this paper
• Changes in antibiotic resistance level of nosocomial Pseudomonas aeruginosa isolates in the largest university hospital of Lithuania.

  2011cites this paper
• Superinfections in Pseudomonas aeruginosa ventilator-associated pneumonia.

  2011cites this paper
• Validation of the American Thoracic Society-Infectious Diseases Society of America guidelines for hospital-acquired pneumonia in the intensive care unit.

  2010cites this paper
• Ventilator Associated Pneumonia: Incidence, Etiology, and Preventive Strategies

  2010cites this paper
• A European survey of antibiotic management of methicillin-resistant Staphylococcus aureus infection: current clinical opinion and practice.

  2010cites this paper
• Inadequate statistical power of published comparative cohort studies on ventilator-associated pneumonia to detect mortality differences.

  2010cites this paper
• Do guidelines change outcomes in ventilator-associated pneumonia?

  2010cites this paper
• Bacterial Etiology of Early- and Late-Onset Ventilator-Associated Pneumonia as Detected With Gram Stain, Endotracheal Aspirate, and Mini-BAL Cultures

  2010cites this paper
• Antibacterial therapy of adult patients with Sepsis

  2010cites this paper
• Multidrug-Resistant Pseudomonas aeruginosa Ventilator-Associated Pneumonia: The Role of Endotracheal Aspirate Surveillance Cultures

  2009cites this paper
• Early- and Late-Onset Pneumonia: Is This Still a Useful Classification?

  2009cites this paper
• Risk factors and treatment patterns of ventilator associated pneumonia in intensive care patients at Kenyatta National Hospital

  2009cites this paper
• Copyright Informa UK Limited 2008 Not for Sale or Comercial Distribution

  2008cites this paper
• Ventilatorassoziierte Pneumonie

  2008cites this paper
• Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia.

  2008cites this paper
• Previous endotracheal aspirate allows guiding the initial treatment of ventilator-associated pneumonia

  2008cites this paper
• Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study*

  2008cites this paper
• Plasticity of the Systemic Inflammatory Response to Acute Infection during Critical Illness: Development of the Riboleukogram

  2008cites this paper
• Ventilator-induced coagulopathy in experimental Streptococcus pneumoniae pneumonia

  2008cites this paper
• MIKROBIOLOGICZNA CHARAKTERYSTYKA ZAPALEŃ PŁUC U PACJENTÓW ODDZIAŁU INTENSYWNEJ TERAPII

  2008cites this paper
• Neumonía nosocomial por grampositivos

  2008cites this paper
• Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter study.

  2008cites this paper
• Ventilatörle İlişkili Pnömoninin Etyopatogenez ve Tanısı

  2008cites this paper
• Evidence-based algorithms for diagnosing and treating ventilator-associated pneumonia.

  2008cites this paper
• Microbiology of Ventilator–Associated Pneumonia Compared With That of Hospital-Acquired Pneumonia

  2007cites this paper
• Nosokomiale und beatmungsassoziierte Pneumonien

  2007cites this paper
• Pneumonies acquises sous ventilation mécanique : suivez les recommandations !

  2007cites this paper